1 Levey AS, "Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate" 145 : 247-254, 2006
2 Kawai T, "Usefulness of the resistive index in renal Doppler ultrasonography as an indicator of vascular damage in patients with risks of atherosclerosis" 26 : 3256-3262, 2011
3 Bader R, "Structure and function of the kidney in diabetic glomerulosclerosis. Correlations between morphological and functional parameters" 167 : 204-216, 1980
4 Cooper CJ, "Stenting and medical therapy for atherosclerotic renal-artery stenosis" 370 : 13-22, 2014
5 Bax L, "Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial" 150 : 840-848, 2009
6 Daijo Inaguma, "Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study" Springer Nature 21 (21): 446-456, 2017
7 ASTRAL Investigators, "Revascularization versus medical therapy for renal-artery stenosis" 361 : 1953-1962, 2009
8 Sugiura T, "Resistive index predicts renal prognosis in chronic kidney disease" 24 : 2780-2785, 2009
9 김은석, "Resistive index as a predictor of acute kidney injury caused by an angiotensin converting enzyme inhibitor or angiotensin II receptor blocker in chronic kidney disease patients" 대한신장학회 32 (32): 158-163, 2013
10 Raff U, "Renal resistive index in addition to low-grade albuminuria complements screening for target organ damage in therapy-resistant hypertension" 28 : 608-614, 2010
1 Levey AS, "Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate" 145 : 247-254, 2006
2 Kawai T, "Usefulness of the resistive index in renal Doppler ultrasonography as an indicator of vascular damage in patients with risks of atherosclerosis" 26 : 3256-3262, 2011
3 Bader R, "Structure and function of the kidney in diabetic glomerulosclerosis. Correlations between morphological and functional parameters" 167 : 204-216, 1980
4 Cooper CJ, "Stenting and medical therapy for atherosclerotic renal-artery stenosis" 370 : 13-22, 2014
5 Bax L, "Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial" 150 : 840-848, 2009
6 Daijo Inaguma, "Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study" Springer Nature 21 (21): 446-456, 2017
7 ASTRAL Investigators, "Revascularization versus medical therapy for renal-artery stenosis" 361 : 1953-1962, 2009
8 Sugiura T, "Resistive index predicts renal prognosis in chronic kidney disease" 24 : 2780-2785, 2009
9 김은석, "Resistive index as a predictor of acute kidney injury caused by an angiotensin converting enzyme inhibitor or angiotensin II receptor blocker in chronic kidney disease patients" 대한신장학회 32 (32): 158-163, 2013
10 Raff U, "Renal resistive index in addition to low-grade albuminuria complements screening for target organ damage in therapy-resistant hypertension" 28 : 608-614, 2010
11 Parolini C, "Renal resistive index and long-term outcome in chronic nephropathies" 252 : 888-896, 2009
12 Radermacher J, "Renal resistance index and progression of renal disease" 39 : 699-703, 2002
13 Muntner P, "Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States" 13 : 745-753, 2002
14 Bigé N, "Renal arterial resistive index is associated with severe histological changes and poor renal outcome during chronic kidney disease" 13 : 139-, 2012
15 Florczak E, "Relationship between renal resistive index and early target organ damage in patients with never-treated essential hypertension" 18 : 55-61, 2009
16 Milovanceva-Popovska M, "Progression of diabetic nephropathy: value of intrarenal resistive index (RI)" 28 : 69-79, 2007
17 Textor SC, "Paradigm shifts in atherosclerotic renovascular disease: where are we now?" 26 : 2074-2080, 2015
18 Bolignano D, "Neutrophil gelatinaseassociated lipocalin (NGAL) and progression of chronic kidney disease" 4 : 337-344, 2009
19 Keith DS, "Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization" 164 : 659-663, 2004
20 National Kidney Foundation, "K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification" 39 (39): S1-S266, 2002
21 Lambers Heerspink HJ, "Is doubling of serum creatinine a valid clinical ‘hard’ endpoint in clinical nephrology trials?" 119 : c195-c199, 2011
22 Raebel MA, "Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers" 30 : e156-e166, 2012
23 Chan JC, "Diabetes in Asia: epidemiology, risk factors, and pathophysiology" 301 : 2129-2140, 2009
24 Ikee R, "Correlation between the resistive index by Doppler ultrasound and kidney function and histology" 46 : 603-609, 2005
25 Ripley E, "Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease" 157 (157): S7-S16, 2009
26 Stratton IM, "Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study" 321 : 405-412, 2000
27 Wang AY, "Angiotensin-converting enzyme inhibitor usage and acute kidney injury: a secondary analysis of RENAL study outcomes" 19 : 617-622, 2014
28 Ishani A, "Acute kidney injury increases risk of ESRD among elderly" 20 : 223-228, 2009
29 Tangri N, "A predictive model for progression of chronic kidney disease to kidney failure" 305 : 1553-1559, 2011
30 Levey AS, "A new equation to estimate glomerular filtration rate" 150 : 604-612, 2009